Israel’s Check-Cap Sells 5% Stake To GE To Advance Imaging Capsule
This article was originally published in PharmAsia News
Executive Summary
Israel’s Check-Cap, which developed a capsule containing an imaging instrument for detecting early versions of colon cancer, has sold a 5% stake to U.S. giant General Electric, reportedly for about $46 million.